Results · Apr-Jun 2026 · filed 5 Aug 2026
Bayer CropScience Q1 FY27 results
Sales fell 4% to ₹1,835 crore from ₹1,915 crore in Apr-Jun 2025.
Operating profit grew 6% to ₹368 crore, an operating margin of 20.0% (up 1.8 points from a year ago).
Net profit grew 15% to ₹322 crore from ₹279 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +67%, net profit +98%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 1,835 | 1,915 | −4% |
| Operating profit (EBITDA) | 367.6 | 348.4 | +6% |
| Operating margin | 20.0% | 18.2% | +1.8 pts |
| Net profit | 321.6 | 278.7 | +15% |
Standalone figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
Filings that week
- 7 Aug 2026Announcement under Regulation 30 (LODR)-Newspaper Publication
- 5 Aug 2026Announcement under Regulation 30 (LODR)-Press Release / Media Release
- 5 Aug 2026Announcement under Regulation 30 (LODR)-Change in Directorate
- 5 Aug 2026Board Meeting Outcome for Outcome Of Board Meeting Held On August 05, 2026
- 5 Aug 2026Unaudited Financial Results For The Quarter Ended June 30, 2026
From the company's results filed on BSE (Standalone). Business numbers only. Education & analysis, not investment advice or a recommendation.